{"id":1356,"date":"2019-11-01T17:28:00","date_gmt":"2019-11-01T16:28:00","guid":{"rendered":"https:\/\/fhu-premimpact.org\/?post_type=publication&#038;p=1356"},"modified":"2020-12-01T15:27:13","modified_gmt":"2020-12-01T14:27:13","slug":"sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic","status":"publish","type":"publication","link":"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/","title":{"rendered":"Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic?"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30403811\">Nephrol Dial Transplant.<\/a>&nbsp;2019 Nov 1;34(11):1819-1826. doi: 10.1093\/ndt\/gfy328.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Abstract<\/h4>\n\n\n\n<p>Preeclampsia is a hypertensive disorder of pregnancy and the clinical manifestation of severe endothelial dysfunction associated with maternal and foetal morbidity and mortality. The primum movens of the disease is the defect of invasion of the uterine arteries by foetal syncytiotrophoblasts, which causes a maladaptive placental response to chronic hypoxia and the secretion of the soluble form of type 1 vascular growth endothelial factor receptor, also called soluble fms-like tyrosine kinase 1 (sFlt-1), the major player in the pathophysiology of the disease. Among its different effects, sFlt-1 induces abnormal sensitivity of the maternal vessels to the vasoconstrictor angiotensin II. This leads to the hypertensive phenotype, recently shown to be abrogated by the administration of sildenafil citrate, which can potentiate the vasodilatory mediator nitrite oxide. This review focuses on the mechanisms of maternal endothelial dysfunction in preeclampsia and discusses the therapeutic window of sildenafil use in the context of preeclampsia, based on the results from preclinical studies and clinical trials. Safety issues recently reported in neonates have considerably narrowed this window.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nephrol Dial Transplant. 2019 Nov 1;34(11):1819-1826. doi: 10.1093\/ndt\/gfy328.<\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-1356","publication","type-publication","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic? - FHU Prem&#039;IMPACT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic? - FHU Prem&#039;IMPACT\" \/>\n<meta property=\"og:description\" content=\"Nephrol Dial Transplant. 2019 Nov 1;34(11):1819-1826. doi: 10.1093\/ndt\/gfy328.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/\" \/>\n<meta property=\"og:site_name\" content=\"FHU Prem&#039;IMPACT\" \/>\n<meta property=\"article:modified_time\" content=\"2020-12-01T14:27:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/\",\"url\":\"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/\",\"name\":\"Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic? - FHU Prem&#039;IMPACT\",\"isPartOf\":{\"@id\":\"https:\/\/fhu-premimpact.org\/en\/#website\"},\"datePublished\":\"2019-11-01T16:28:00+00:00\",\"dateModified\":\"2020-12-01T14:27:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/fhu-premimpact.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Publications\",\"item\":\"https:\/\/fhu-premimpact.org\/en\/publications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fhu-premimpact.org\/en\/#website\",\"url\":\"https:\/\/fhu-premimpact.org\/en\/\",\"name\":\"FHU PREM'IMPACT\",\"description\":\"Perinatal inflammation and prematurity\",\"publisher\":{\"@id\":\"https:\/\/fhu-premimpact.org\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fhu-premimpact.org\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fhu-premimpact.org\/en\/#organization\",\"name\":\"FHU PREM'IMPACT\",\"url\":\"https:\/\/fhu-premimpact.org\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fhu-premimpact.org\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fhu-premimpact.org\/wp-content\/uploads\/2025\/03\/logo-grand-centre-fhupremimpact.jpg\",\"contentUrl\":\"https:\/\/fhu-premimpact.org\/wp-content\/uploads\/2025\/03\/logo-grand-centre-fhupremimpact.jpg\",\"width\":1280,\"height\":720,\"caption\":\"FHU PREM'IMPACT\"},\"image\":{\"@id\":\"https:\/\/fhu-premimpact.org\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.instagram.com\/fhupremimpact\/\",\"https:\/\/www.linkedin.com\/in\/fhu-prem-impact-ap-hp-inserm-universit-paris-cit-70b911253\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic? - FHU Prem&#039;IMPACT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/","og_locale":"en_US","og_type":"article","og_title":"Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic? - FHU Prem&#039;IMPACT","og_description":"Nephrol Dial Transplant. 2019 Nov 1;34(11):1819-1826. doi: 10.1093\/ndt\/gfy328.","og_url":"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/","og_site_name":"FHU Prem&#039;IMPACT","article_modified_time":"2020-12-01T14:27:13+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/","url":"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/","name":"Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic? - FHU Prem&#039;IMPACT","isPartOf":{"@id":"https:\/\/fhu-premimpact.org\/en\/#website"},"datePublished":"2019-11-01T16:28:00+00:00","dateModified":"2020-12-01T14:27:13+00:00","breadcrumb":{"@id":"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fhu-premimpact.org\/en\/publications\/sildenafil-for-the-treatment-of-preeclampsia-an-update-should-we-still-be-enthusiastic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/fhu-premimpact.org\/en\/"},{"@type":"ListItem","position":2,"name":"Publications","item":"https:\/\/fhu-premimpact.org\/en\/publications\/"},{"@type":"ListItem","position":3,"name":"Sildenafil for the treatment of preeclampsia, an update: should we still be enthusiastic?"}]},{"@type":"WebSite","@id":"https:\/\/fhu-premimpact.org\/en\/#website","url":"https:\/\/fhu-premimpact.org\/en\/","name":"FHU PREM'IMPACT","description":"Perinatal inflammation and prematurity","publisher":{"@id":"https:\/\/fhu-premimpact.org\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fhu-premimpact.org\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fhu-premimpact.org\/en\/#organization","name":"FHU PREM'IMPACT","url":"https:\/\/fhu-premimpact.org\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fhu-premimpact.org\/en\/#\/schema\/logo\/image\/","url":"https:\/\/fhu-premimpact.org\/wp-content\/uploads\/2025\/03\/logo-grand-centre-fhupremimpact.jpg","contentUrl":"https:\/\/fhu-premimpact.org\/wp-content\/uploads\/2025\/03\/logo-grand-centre-fhupremimpact.jpg","width":1280,"height":720,"caption":"FHU PREM'IMPACT"},"image":{"@id":"https:\/\/fhu-premimpact.org\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.instagram.com\/fhupremimpact\/","https:\/\/www.linkedin.com\/in\/fhu-prem-impact-ap-hp-inserm-universit-paris-cit-70b911253\/"]}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false,"twentytwenty-fullscreen":false},"uagb_author_info":{"display_name":"Laurence Lecomte","author_link":"https:\/\/fhu-premimpact.org\/en\/author\/"},"uagb_comment_info":0,"uagb_excerpt":"Nephrol Dial Transplant. 2019 Nov 1;34(11):1819-1826. doi: 10.1093\/ndt\/gfy328.","_links":{"self":[{"href":"https:\/\/fhu-premimpact.org\/en\/wp-json\/wp\/v2\/publication\/1356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fhu-premimpact.org\/en\/wp-json\/wp\/v2\/publication"}],"about":[{"href":"https:\/\/fhu-premimpact.org\/en\/wp-json\/wp\/v2\/types\/publication"}],"wp:attachment":[{"href":"https:\/\/fhu-premimpact.org\/en\/wp-json\/wp\/v2\/media?parent=1356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}